Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001600132-17-000124
Filing Date
2017-11-07
Accepted
2017-11-07 08:43:12
Documents
52
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q blph09301710q.htm 10-Q 784278
2 EXHIBIT 31.1 blph09301710qexhibit311.htm EX-31.1 9899
3 EXHIBIT 31.2 blph09301710qexhibit312.htm EX-31.2 9877
4 EXHIBIT 32 blph09301710qexhibit32.htm EX-32 10863
  Complete submission text file 0001600132-17-000124.txt   4138241

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT blph-20170930.xml EX-101.INS 656222
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blph-20170930.xsd EX-101.SCH 35248
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT blph-20170930_cal.xml EX-101.CAL 50223
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT blph-20170930_def.xml EX-101.DEF 211207
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blph-20170930_lab.xml EX-101.LAB 507430
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blph-20170930_pre.xml EX-101.PRE 316195
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)

EIN.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36845 | Film No.: 171181228
SIC: 2834 Pharmaceutical Preparations